Emma Tinsley is the founder of Elevara Medicine. Elevara Medicine has raised $70M in total funding. Latest round: Series A. Based in London, UK.
Emma Tinsley is the CEO of Elevara Medicines, a London-based clinical-stage biotechnology company focused on developing therapies for rheumatoid arthritis and chronic inflammatory diseases. She led the company through a $70 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library